| CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo M Rashighi, P Agarwal, JM Richmond, TH Harris, K Dresser, MW Su, ... Science translational medicine 6 (223), 223ra23-223ra23, 2014 | 448 | 2014 |
| 乳鼠心肌提取 HHS Public Access M Rashighi, JE Harris Physiol Behav 176 (3), 139-148, 2017 | 445 | 2017 |
| New discoveries in the pathogenesis and classification of vitiligo M Rodrigues, K Ezzedine, I Hamzavi, AG Pandya, JE Harris, ... Journal of the American Academy of Dermatology 77 (1), 1-13, 2017 | 411 | 2017 |
| A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8+ T-cell accumulation in the skin JE Harris, TH Harris, W Weninger, EJ Wherry, CA Hunter, LA Turka Journal of Investigative Dermatology 132 (7), 1869-1876, 2012 | 398 | 2012 |
| Vitiligo: mechanisms of pathogenesis and treatment ML Frisoli, K Essien, JE Harris Annual review of immunology 38, 621-648, 2020 | 270 | 2020 |
| Vitiligo pathogenesis and emerging treatments M Rashighi, JE Harris Dermatologic clinics 35 (2), 257-265, 2017 | 224 | 2017 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 219 | 2022 |
| Innate immune mechanisms in vitiligo: danger from within JM Richmond, ML Frisoli, JE Harris Current opinion in immunology 25 (6), 676-682, 2013 | 216 | 2013 |
| Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA) JE Harris, M Rashighi, N Nguyen, A Jabbari, G Ulerio, R Clynes, ... Journal of the American Academy of Dermatology 74 (2), 370-371, 2016 | 206 | 2016 |
| Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure LY Liu, JP Strassner, MA Refat, JE Harris, BA King Journal of the American Academy of Dermatology 77 (4), 675-682. e1, 2017 | 199 | 2017 |
| Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo JM Richmond, JP Strassner, L Zapata Jr, M Garg, RL Riding, MA Refat, ... Science Translational Medicine 10 (450), eaam7710, 2018 | 191 | 2018 |
| Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial D Rosmarin, AG Pandya, M Lebwohl, P Grimes, I Hamzavi, AB Gottlieb, ... The Lancet 396 (10244), 110-120, 2020 | 190 | 2020 |
| Immunology and skin in health and disease JM Richmond, JE Harris Cold Spring Harbor perspectives in medicine 4 (12), a015339, 2014 | 190 | 2014 |
| Current and emerging treatments for vitiligo M Rodrigues, K Ezzedine, I Hamzavi, AG Pandya, JE Harris, ... Journal of the American Academy of Dermatology 77 (1), 17-29, 2017 | 188 | 2017 |
| Human Slug is a repressor that localizes to sites of active transcription K Hemavathy, SC Guru, J Harris, JD Chen, YT Ip Molecular and cellular biology, 2000 | 185 | 2000 |
| A network of high-mobility group box transcription factors programs innate interleukin-17 production N Malhotra, K Narayan, OH Cho, KE Sylvia, C Yin, H Melichar, ... Immunity 38 (4), 681-693, 2013 | 172 | 2013 |
| Early growth response gene-2, a zinc-finger transcription factor, is required for full induction of clonal anergy in CD4+ T cells JE Harris, KD Bishop, NE Phillips, JP Mordes, DL Greiner, AA Rossini, ... The Journal of Immunology 173 (12), 7331-7338, 2004 | 162 | 2004 |
| Keratinocyte-derived chemokines orchestrate T-cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease JM Richmond, DS Bangari, KI Essien, SD Currimbhoy, JR Groom, ... Journal of Investigative Dermatology 137 (2), 350-358, 2017 | 161 | 2017 |
| Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo M Rashighi, JE Harris Annals of translational medicine 3 (21), 2015 | 140 | 2015 |
| CXCR4 identifies transitional bone marrow premonocytes that replenish the mature monocyte pool for peripheral responses SZ Chong, M Evrard, S Devi, J Chen, JY Lim, P See, Y Zhang, JM Adrover, ... Journal of Experimental Medicine 213 (11), 2293-2314, 2016 | 135 | 2016 |
Mehdi RashighiDepartment of Dermatology, University of Massachusetts Medical SchoolAdresse e-mail validée de umassmed.edu
